This is inverse to the published literature showing that there is a lower CD8/Treg ratio in metastatic site compared with primary site, likely due to immune evasion and escape, though in other tumor types like breast and colorectal cancers (58, 59). This evidence concerns the gene CD8A and neoplasm.